Riskpilot← Back to searchSign inGet full accessVitalface AB
ABActiveOrg 5569265803Sveciagatan 19Medical specialists activities · NACE 8622Est. 20132 employees
Revenue 2024
SEK 4,8M
+31% vs 2023
EBITDA margin
22.0%
-34% vs 2023
Equity ratio
58.1%
Financial strength
Net profit 2024
SEK 546K
-44% vs 2023
| Revenue | SEK 4,8M | +31% |
| EBITDA | SEK 1,1M | -34% |
| Net profit | SEK 546K | -44% |
| Total assets | SEK 5M | -1% |
| Equity | SEK 2,9M | +13% |
| Employees | 2 | — |
Legal name
Vitalface AB
Org number
5569265803
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
21 mars 2013
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Kosmetiska behandlingar och kosmetiska operationer t.ex. bröstoperationer, -förminskning, -lyft och -rekonstruktion. Laserbehandlingar, peels, injektionsbehandlingar och massage, specialistbehandling mot håravfall eller generande hårväxt.
Address
Sveciagatan 19
Email
klinik@rcscanning.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 509 | 2 349 | 2 875 | 3 665 | 4 810 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 156 | 1 713 | 1 962 | 1 598 | 1 056 |
| Depreciation & amort. | −0 | −0 | −100 | −100 | −100 |
| EBIT | 156 | 1 713 | 1 862 | 1 498 | 956 |
| Net financials | — | −1 | −6 | −28 | −34 |
| Profit before tax | 117 | 1 284 | 1 393 | 1 257 | 701 |
| Tax | −25 | −268 | −498 | −278 | −155 |
| Net profit | 92 | 1 016 | 895 | 979 | 546 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 439 | 2 553 | 4 507 | 5 028 | 4 959 |
| Equity | 51 | 1 067 | 1 961 | 2 541 | 2 881 |
| Long-term debt | 53 | 55 | 286 | 244 | 215 |
| Short-term debt | 266 | 934 | 1 298 | 1 069 | 464 |
| Total debt | 319 | 989 | 1 584 | 1 313 | 679 |
EBITDA margin
22.0%
This company
15.8%
Market median
+39% vs market
20202024
Equity ratio
58.1%
This company
38.2%
Market median
+52% vs market
20202024
Return on equity
19.0%
This company
18.4%
Market median
+3% vs market
20202024
Net profit margin
11.4%
This company
8.1%
Market median
+41% vs market
20202024
Asset turnover
0.97×
This company
1.12×
Market median
+13% vs market
20202024
Debt / equity
0.72×
This company
0.62×
Market median
+16% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
DR Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Vitalface AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| David Ramin Assjodi | Chief Executive Officer | 0 companies |
| Neda Zare | Deputy Board Member | 0 companies |